Sign in

CIK 0001357459 · Non-accelerated filer<br>Smaller reporting company

PALISADE BIO, INC.

Sign in to watch
Ticker
PALI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
522007292
Phone
(858) 704-4900
Business address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
Former names
PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Grant or award Director acquired 45,046 shares (grant or award)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award Director acquired 18,622 shares (grant or award)
  12. 4 Derivatives Options or other derivatives
  13. 4 Grant or award Director acquired 18,622 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market buy Chief Executive Officer bought 7,500 shares at $4.00 ($30,000)
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market buy Chief Financial Officer bought 5,455 shares at $5.50 ($30,003)
  18. 4 Open-market buy Chief Executive Officer bought 2,591 shares at $3.86 ($10,001)
  19. 4 Open-market buy Chief Executive Officer bought 2,841 shares at $3.52 ($10,000)
  20. 4 Open-market buy Chief Executive Officer bought 32,259 shares at $0.31 ($10,000)

Page 9 of 18 · 343 filings